In New York on January 5, 2026, the law firm Purcell & Lefkowitz LLP disclosed its investigation into Citius Oncology, Inc. (NASDAQ: CTOR) for the benefit of the shareholders. This inquiry aims to assess whether the directors of Citius Oncology may have violated their fiduciary responsibilities towards the company and its stakeholders.